Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2007-08-28

FDA Approved: AMLODIPINE BESYLATE — Original Application (Cipla USA Inc.)

View source ↗

Summary

FDA approved Cipla USA Inc.'s original application for amlodipine besylate, a generic calcium channel blocker used to treat hypertension and angina. This marks …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Amlodipine besylate (amlodipine besylate)

Snippet

ORIG AP for AMLODIPINE BESYLATE (AMLODIPINE BESYLATE)